[HTML][HTML] Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - europepmc.org
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network Models of Prostate Cancer Immune Microenvironments Identify ROMO1 as Heterogeneity and Prognostic Marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin, Y Zhang… - 2021 - researchsquare.com
Background: Prostate cancer (PCa) is the fifth leading cause of death from cancer in men
worldwide. Its treatment remains challenging due to the heterogeneity of the tumor, mainly …
worldwide. Its treatment remains challenging due to the heterogeneity of the tumor, mainly …
[HTML][HTML] Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
[PDF][PDF] Network Models of Prostate Cancer Immune Microenvironments Identify ROMO1 as Heterogeneity and Prognostic Marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin, Y Zhang… - scholar.archive.org
Abstract Background: Prostate cancer (PCa) is the fth leading cause of death from cancer in
men worldwide. Its treatment remains challenging due to the heterogeneity of the tumor …
men worldwide. Its treatment remains challenging due to the heterogeneity of the tumor …
Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - search.ebscohost.com
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - ui.adsabs.harvard.edu
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin… - Scientific …, 2022 - scholars.cityu.edu.hk
Prostate cancer (PCa) is the fifth leading cause of death from cancer in men worldwide. Its
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
treatment remains challenging due to the heterogeneity of the tumor, mainly because of the …
Network Models of Prostate Cancer Immune Microenvironments Identify ROMO1 as Heterogeneity and Prognostic Marker
L Wang, X Liu, Z Liu, Y Wang, M Fan, J Yin, Y Zhang… - 2021 - europepmc.org
Background: Prostate cancer (PCa) is the fifth leading cause of death from cancer in men
worldwide. Its treatment remains challenging due to the heterogeneity of the tumor, mainly …
worldwide. Its treatment remains challenging due to the heterogeneity of the tumor, mainly …